Yu.O. Tyumenkov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yu.O. Tyumenkov has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr Andreevich Tulupov
Privolzhsky Research Medical University
2 shared publications - Olga V. Kovalishena
Privolzhsky Research Medical University
2 shared publications - Vladimir Viktorovich Beschastnov
Privolzhsky Research Medical University
2 shared publications - Emil Firdavisovich Badikov
Privolzhsky Research Medical University
1 shared publication I.Yu. Shirokova
1 shared publication- Igor Evgenievich Pogodin
Privolzhsky Research Medical University
1 shared publication
Latest Publications
- Open Access
- 10 September 2024
- Published by RPO Surgical Society - Wound and Wound Infections in Wounds and wound infections. The prof. B.M. Kostyuchenok journal
- Vol. 10 (3) , 22-32
Is it possible to use wound dressings as carriers of bacteriophages and lactobacilli? In vitro study
Objective: To find wound dressings which could incorporate solutions of bacteriophages and lactobacilli and could have potential to overcomemicroorganism resistance to antibiotic therapy. Material and methods. Physicochemical and biological properties of 12 samples of wound coverings of different structures and properties which had been used for combustion wounds were analyzed. Wound dressings differed in their keystone structure (biopolymers of natural and artificial origin) and in biodegradability. The following properties of wound dressings were studied in vitro: absorption, biological inertness and duration of viability / lytic activity of staphylococcal bacteriophage and antagonistic activity of L. plantarum inoculum. In addition, own antibacterial activity of wound dressings against S. aureus culture was studied too. Research results. Among the studied wound dressings, the largest mass of liquid can be absorbed by the following wound dressings: Likosorb®, Fibrosorb®, Biatraum®, Hitokol-S®. All studied wound coverings are biologically inert towards the staphylococcal bacteriophage (they ensure the formation of zones of S. aureus lysis). Viability of L. plantarum inoculum was promoted by wound coverings OPSITE® Post-Op Visible, Fibrosorb®, Algipran®, Biatraum®. Wound coverings OPSITE® Post-Op Visible, Fibrosorb®, Likosorb® maintain the lytic activity of staphylococcal bacteriophage up to 7 days. L. plantarum viability for up to 2 days was registered in Fibrosorb® wound covering, up to 3 days – in OPSITE® Post-Op Visible. Wound coverings Chitokol-S®, Kollakhit® FA, Algipran® and Aquacel Ag® have their own antibacterial activity against S. aureus; when they were saturated with staphylococcal bacteriophage solution, their antibacterial activity increased. Conclusion. Wound coverings with sponge structure based on chitosan and polyurethane exhibit the greatest absorption level of inoculum solutions of L. plantarum and staphylococcal bacteriophage maintaining their viability / lytic activity.
- 10 September 2024
- Published by RPO Surgical Society - Wound and Wound Infections in Wounds and wound infections. The prof. B.M. Kostyuchenok journal
- Vol. 10 (3) , 22-32
Open AccessIs it possible to use wound dressings as carriers of bacteriophages and lactobacilli? In vitro study
Objective: To find wound dressings which could incorporate solutions of bacteriophages and lactobacilli and could have potential to overcomemicroorganism resistance to antibiotic therapy. Material and methods. Physicochemical and biological properties of 12 samples of wound coverings of different structures and properties which had been used for combustion wounds were analyzed. Wound dressings differed in their keystone structure (biopolymers of natural and artificial origin) and in biodegradability. The following properties of wound dressings were studied in vitro: absorption, biological inertness and duration of viability / lytic activity of staphylococcal bacteriophage and antagonistic activity of L. plantarum inoculum. In addition, own antibacterial activity of wound dressings against S. aureus culture was studied too. Research results. Among the studied wound dressings, the largest mass of liquid can be absorbed by the following wound dressings: Likosorb®, Fibrosorb®, Biatraum®, Hitokol-S®. All studied wound coverings are biologically inert towards the staphylococcal bacteriophage (they ensure the formation of zones of S. aureus lysis). Viability of L. plantarum inoculum was promoted by wound coverings OPSITE® Post-Op Visible, Fibrosorb®, Algipran®, Biatraum®. Wound coverings OPSITE® Post-Op Visible, Fibrosorb®, Likosorb® maintain the lytic activity of staphylococcal bacteriophage up to 7 days. L. plantarum viability for up to 2 days was registered in Fibrosorb® wound covering, up to 3 days – in OPSITE® Post-Op Visible. Wound coverings Chitokol-S®, Kollakhit® FA, Algipran® and Aquacel Ag® have their own antibacterial activity against S. aureus; when they were saturated with staphylococcal bacteriophage solution, their antibacterial activity increased. Conclusion. Wound coverings with sponge structure based on chitosan and polyurethane exhibit the greatest absorption level of inoculum solutions of L. plantarum and staphylococcal bacteriophage maintaining their viability / lytic activity.
- Open Access
- 1 January 2023
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 11 (3)
Experimental evaluation of clinical and microbiological efficacy of systemic antibiotic therapy and local phage therapy in surgical treatment of burn wound infection
Экспериментальная оценка клинико-микробиологической эффективности системной антибиотикотерапии и местной фаготерапии при хирургическом лечении
- 1 January 2023
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 11 (3)
Open AccessExperimental evaluation of clinical and microbiological efficacy of systemic antibiotic therapy and local phage therapy in surgical treatment of burn wound infection
Экспериментальная оценка клинико-микробиологической эффективности системной антибиотикотерапии и местной фаготерапии при хирургическом лечении